» Articles » PMID: 30980099

Distinct FP-CIT PET Patterns of Alzheimer's Disease with Parkinsonism and Dementia with Lewy Bodies

Overview
Date 2019 Apr 14
PMID 30980099
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Little is known regarding the clinical relevance or neurobiology of subtle motor disturbance in Alzheimer's disease (AD). This study aims to investigate the patterns of striatal F-FP-CIT uptake in patients with AD-related cognitive impairment (ADCI) with mild parkinsonism.

Methods: We recruited 29 consecutive patients with ADCI with mild parkinsonism. All patients underwent F-FP-CIT PET scans and dopamine transporter (DAT) availability in striatal subregions (anterior/posterior caudate, anterior/posterior putamen, ventral putamen, ventral striatum) was quantified. Additionally, 32 patients with dementia with Lewy bodies (DLB) and 21 healthy controls were included to perform inter-group comparative analyses of the striatal DAT availability. The discriminatory power of striatal DAT availability to differentiate ADCI from DLB was assessed using receiver operating characteristics (ROC) analyses. The Spearman's correlation coefficient was calculated to assess the relationship between motor severity and DAT availability in striatal subregions.

Results: Patients with ADCI with mild parkinsonism exhibited decreased DAT availability in the caudate that was intermediate between healthy controls and patients with DLB. The DAT availability in other striatal subregions, including the posterior putamen, did not differ between the ADCI with parkinsonism and healthy control groups. The ROC analysis showed that DAT availability of all striatal subregions, especially the whole striatum, had a fair discriminatory power. Parkinsonian motor severity did not correlate with the striatal DAT availability in ADCI with parkinsonism.

Conclusions: The present study demonstrated that patients with ADCI with mild parkinsonism had distinct DAT scan patterns and suggests that parkinsonism is associated with the extranigral source of pathology.

Citing Articles

Hybrid PET/MRI in Neurodegenerative Disorders.

Keir G, Li Y, Chiang G Adv Clin Radiol. 2024; 6(1):121-135.

PMID: 39583180 PMC: 11583654. DOI: 10.1016/j.yacr.2024.04.013.


Atypical Parkinsonian Syndromes: Structural, Functional, and Molecular Imaging Features.

Keir G, Roytman M, Mashriqi F, Shahsavarani S, Franceschi A AJNR Am J Neuroradiol. 2024; 45(12):1865-1877.

PMID: 39209485 PMC: 11630880. DOI: 10.3174/ajnr.A8313.


Imaging Procedure and Clinical Studies of [F]FP-CIT PET.

Sung C, Oh S, Kim J Nucl Med Mol Imaging. 2024; 58(4):185-202.

PMID: 38932763 PMC: 11196481. DOI: 10.1007/s13139-024-00840-x.


It Is Time to Study Overlapping Molecular and Circuit Pathophysiologies in Alzheimer's and Lewy Body Disease Spectra.

Wakasugi N, Hanakawa T Front Syst Neurosci. 2021; 15:777706.

PMID: 34867224 PMC: 8637125. DOI: 10.3389/fnsys.2021.777706.

References
1.
Wolf D, Gearing M, Snowdon D, Mori H, Markesbery W, Mirra S . Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. Alzheimer Dis Assoc Disord. 1999; 13(4):226-31. DOI: 10.1097/00002093-199910000-00009. View

2.
Almeida O, Burton E, McKeith I, Gholkar A, Burn D, OBrien J . MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord. 2003; 16(2):57-63. DOI: 10.1159/000070676. View

3.
Walker Z, Costa D, Walker R, Lee L, Livingston G, Jaros E . Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. Neurology. 2004; 62(9):1568-72. DOI: 10.1212/01.wnl.0000123248.39847.1d. View

4.
OBrien J, Colloby S, Fenwick J, Williams E, Firbank M, Burn D . Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol. 2004; 61(6):919-25. DOI: 10.1001/archneur.61.6.919. View

5.
Ceravolo R, Volterrani D, Gambaccini G, Bernardini S, Rossi C, Logi C . Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study. J Neural Transm (Vienna). 2004; 111(8):1065-73. DOI: 10.1007/s00702-004-0140-0. View